Blood Biomarkers
Blood Biomarkers - Related Videos
07:20
Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
0 Views •
Cited by 65 •
2014
Biomarkers are directly-measured biological indicators of disease or health. In population and social sciences, biomarkers need to be easy to obtain, transport, and analyze. Dried Blood Spot (DBS) collection meets this need, can be collected in the field with high response rates and analyzed for a variety of biomarkers.
01:20
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
0 Views •
2025
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging. The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include: Troponins Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
08:29
Biomarkers in an Animal Model for Revealing Neural, Hematologic, and Behavioral Correlates of PTSD
0 Views •
Cited by 29 •
2012
We describe a rat model of post traumatic stress disorder (PTSD) that reveals the persistent alterations in neuroendocrine function and the delayed long-term, exaggerated fear response, characteristic of PTSD patients. The animal model and methods described here are useful for correlating biomarkers in brain nuclei, which are mechanistic but cannot be measured in patients, with biomarkers in peripheral white blood cells, which can.
09:00
High Throughput Sequential ELISA for Validation of Biomarkers of Acute Graft-Versus-Host Disease
0 Views •
Cited by 14 •
2012
High throughput validation of multiple candidate biomarkers can be performed by sequential ELISA in order to minimize freeze/thaw cycles and use of precious plasma samples. Here, we demonstrate how to sequentially perform ELISAs for six different validated plasma biomarkers1-3 of graft-versus-host disease (GVHD)4 on the same plasma sample.
08:28
An Overview of bGDGT Biomarker Analysis for Paleoclimatology
0 Views •
2023
Source: Laboratory of Jeff Salacup - University of Massachusetts Amherst Throughout this series of videos, natural samples were extracted and purified in search of organic compounds, called biomarkers, that can relate information on climates and environments of the past. One of the samples analyzed was sediment. Sediments accumulate over geologic time in basins, depressions in the Earth into which sediment flows through the action of fluid (water or air), movement, and gravity. Two main types...
FAQs
Blood biomarkers can originate when tissues or circulating systems contribute measurable signals to the bloodstream. These signals may include proteins, metabolites, nucleic acids, immune signals, cells, or other measurable features. Their presence links a blood measurement to biological activity elsewhere in the body, allowing investigators to study systemic changes without directly measuring every tissue.
Changes can reflect altered cellular activity, tissue release, or shifts in circulating biological systems. The measured concentration or characteristics may therefore differ between normal activity, disease, and treatment response. This makes the same type of signal useful for identifying biological change and for following whether an intervention is associated with a changed state.
These assay classes examine blood signals through different measurement approaches. Biochemical assays can target measurable chemical features, immunological assays detect signals through immune-based recognition, and molecular assays analyze nucleic-acid-related information. Choosing among them depends on the signal being studied and determines which molecular, cellular, or biochemical characteristics become available for interpretation.
Researchers seek indicators that can detect relevant biological changes sensitively while distinguishing those changes specifically from other signals. Improved sensitivity and specificity are continuing research goals, particularly for early diagnosis and personalized care. Better performance could make measurements more informative when interpreting disease-related changes and distinguishing meaningful biological states.
An analysis begins with a blood sample represented as plasma, serum, or whole blood. A laboratory then applies a suitable biochemical, immunological, or molecular assay to measure the selected signal or feature. The resulting concentration or characteristic is interpreted in relation to normal activity, disease, treatment response, or another health-related change.
Blood measurements can support several stages of biological and medical investigation: disease detection, risk assessment, prognosis, patient monitoring, and drug development. Because the measured signals may change with disease or treatment, they can contribute both to evaluating a person's biological state and to tracking responses during research or care.
In drug development, blood measurements can provide biological evidence alongside other study information. Signals may be examined for changes associated with treatment response, while monitoring can help characterize how a biological state changes during investigation. This supports evaluation of candidate interventions and connects laboratory measurements with disease-focused research.